FRIDAY, October 16, 2009 Poster Area
Poster Session P-2/6: IMMUNOPHARMACOLOGY
Poster Commission Members: President: Patrono C. (Rome) Members: Tremoli E. (Milan), Ziche M. (Siena)
(1 award)
ACUTE PANCREATITIS IS REDUCED BY GENETIC OR PHARMACOLOGICAL INHIBITION OF GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR).
Galuppo M., Nocentini G., Mazzon E., Esposito E., Di Paola R., Crisafulli C., Genovese T., Riccardi C., Cuzzocrea . (Messina, Perugia, Napoli) |
POST-TRANSLATIONAL MODIFICATION OF GILZ BY SUMO-1
Pozzesi N., Riccardi C., Delfino D. (Perugia) |
GITR+CD25- CELLS REPRESENT A HUMAN REGULATORY T CELLS SUBSET DEREGULATED IN SYSTEMIC LUPUS ERYTHEMATOSUS
Bianchini R., Nocentini G., Petrillo M., Bistoni O., Alunno A., Ronchetti S., Bartoloni Bocci E., Gerli R., Riccardi C. (Perugia) |
EXPRESSION AND SIGNALLING OF PPAR-GAMMA IN SH-SY5Y, A HUMAN NEUROBLASTOMA CELL LINE
Palma A., Amoruso A., Fresu L., Bardelli C., Brunelleschi S. (Novara) |
IMPACT OF TOBACCO SMOKE IN PPARGAMMA EXPRESSION IN MONOCYTE/MACROPHAGES ISOLATED FROM CORONARY HEART DISEASE (CHD) PATIENTS
Amoruso A., Bardelli C., Fresu L., Palma A., Brunelleschi S. (Novara) |
MYCOPHENOLIC ACID THERAPEUTIC DRUG MONITORING BY MEANS OF A LIMITED SAMPLING STRATEGY IN ADULT HEART TRANSPLANT PATIENTS
BARALDO M., FERUGLIO M., COJUTTI P., TURSI V., LIVI U., FURLANUT M. (Udine) |
SULFATIDE AS AN ENDOGENOUS MODULATOR OF INDOLEAMINE 2,3-DIOXYGENASE IN ANTIGEN PRESENTING CELLS
Fallarini S., Altomare E., Mossotti M., Panza L., Lombardi G. (Novara) |
ENDOGENOUS CATECHOLAMINES IN HUMAN NATURAL KILLER CELLS: BASIC EVIDENCE AND CLINICAL IMPLICATIONS
Maio R., Bozzo L., Brunetta E., Bonaldo S., Marino F., Mavilio D., Cosentino M. (Varese, Rozzano MI) |
POSSIBLE LINK BETWEEN HISTORY OF HYPERSENSITIVITY TO A SPECIFIC NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) AND POSITIVE RESULTS FOLLOWING CHALLENGE TEST TO ALTERNATIVE NSAIDS
Naccari C., Trombetta D., Imbesi S., Vita G., Isola S., Minciullo P., Saija A., Gangemi S. (Messina) |
IMPAIRMENT OF DENDRITIC CELL FUNCTION IS CRUCIAL FOR PROTECTION AFFORDED BY PARP-1 INHIBITORS IN EXPERIMENTAL MODELS OF MULTIPLE SCELROSIS
Cavone L., Aldinucci A., Ballerini C., Biagioli T., Massacesi L., Moroni F., Chiarugi A. (Firenze) |